Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
79°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kymera Therapeutics Inc
(NQ:
KYMR
)
42.20
-0.90 (-2.09%)
Streaming Delayed Price
Updated: 12:57 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Kymera Therapeutics Inc
< Previous
1
2
3
4
Next >
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Kymera Therapeutics's Return On Capital Employed Insights
February 27, 2023
Via
Benzinga
Analyst Ratings for Kymera Therapeutics
February 24, 2023
Via
Benzinga
7 Perfect Presents to Gift Your 2023 Stock Portfolio
December 21, 2022
As we leave 2022 behind, these hot stocks to buy have significant potential and serious catalysts as we move into New Year 2023.
Via
InvestorPlace
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
December 14, 2022
Business wins are shining the spotlight on these two companies.
Via
The Motley Fool
What 4 Analyst Ratings Have To Say About Kymera Therapeutics
December 06, 2022
Via
Benzinga
Looking Into Kymera Therapeutics's Return On Capital Employed
November 22, 2022
Via
Benzinga
Where Kymera Therapeutics Stands With Analysts
November 08, 2022
Analysts have provided the following ratings for Kymera Therapeutics (NASDAQ:KYMR) within the last quarter:
Via
Benzinga
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 50 Stocks Moving In Wednesday's Mid-Day Session
December 14, 2022
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
Via
Benzinga
Dear DS Stock Fans, Mark Your Calendars for Dec. 23
December 14, 2022
Drive Shack (DS) stock is falling hard on Wednesday after the company warned investors of it delisting shares this month.
Via
InvestorPlace
Why Is SOFI Stock Up 7% Today?
December 14, 2022
SoFi Technologies (SOFI) stock is climbing higher on Wednesday after the company's CEO bought over 1 million more shares.
Via
InvestorPlace
5 Analysts Have This to Say About Kymera Therapeutics
November 08, 2022
Analysts have provided the following ratings for Kymera Therapeutics (NASDAQ:KYMR) within the last quarter:
Via
Benzinga
5 Analysts Have This to Say About Kymera Therapeutics
November 04, 2022
Kymera Therapeutics (NASDAQ:KYMR) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Recap: Kymera Therapeutics Q3 Earnings
November 03, 2022
Kymera Therapeutics (NASDAQ:KYMR) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Dear CRKN Stock Fans, Mark Your Calendars for Dec. 22
December 14, 2022
Crown Electrokinetics (CRKN) stock is on the move Wednesday as investors prepare for the company's upcoming shareholder meeting.
Via
InvestorPlace
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?
December 14, 2022
KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase.
Via
InvestorPlace
REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday
December 14, 2022
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Kymera Therapeutics Stock Jumps After Positive Data From Atopic Dermatitis Trial
December 14, 2022
Via
Benzinga
US Stocks Higher Ahead Of Fed Decision
December 14, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining over 80 points on Wednesday
Via
Benzinga
Why Small Biotech Kymera Just Snagged Sanofi's Interest And Surged 28%
December 14, 2022
The company is working on protein degradation in cancer and inflammatory diseases.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 14, 2022
Via
Benzinga
JetBlue Airways, Pacira BioSciences And Some Other Big Stocks Moving Lower On Tuesday
December 13, 2022
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 70 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday
December 06, 2022
Via
Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
Kymera Gets Orphan Drug Status For Rare Blood Cancer Candidate
September 15, 2022
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Kymera Therapeutics’ (NASDAQ: KYMR) product candidate KT-333 for the treatment of Cutaneous T-cell Lymphoma (CTCL).
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
November 08, 2022
Upgrades
Via
Benzinga
Looking Into Kymera Therapeutics's Return On Capital Employed
September 02, 2022
Kymera Therapeutics (NASDAQ:KYMR) brought in sales totaling $11.51 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 9.74%, resulting in a loss of $40.26...
Via
Benzinga
Where Kymera Therapeutics Stands With Analysts
August 29, 2022
Over the past 3 months, 6 analysts have published their opinion on Kymera Therapeutics (NASDAQ:KYMR) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Insiders Buying Ecolab, Kymera Therapeutics And This Consumer Cyclical Stock
August 24, 2022
Although US stocks closed mostly lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.